Glial cell activity is maintained during prolonged inflammatory challenge in rats.

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Lipopolysaccharide (LPS) is a potent activator of glial cells, inducing neuroinflammation.
• Glial activation is implicated in both the initiation and resolution of inflammatory processes in the brain.
• Understanding glial responses to LPS is crucial for developing therapeutic strategies for neuroinflammatory conditions.

Purpose of the Study:

• To investigate the effects of single and repeated lipopolysaccharide (LPS) administration on glial activation markers in the rat brain.
• To evaluate the expression of glial fibrillary acidic protein (GFAP), glutamine synthetase (GS), ionized calcium binding adaptor protein-1 (Iba-1), and ferritin following LPS treatment.
• To determine if repeated LPS exposure modulates glial responses and potentially influences neuronal protection.

Main Methods:

• Male Wistar rats were administered saline or LPS (100 µg/kg) via intraperitoneal injection for six consecutive days.
• Experimental groups included: 6 saline injections, 5 saline + 1 LPS injection, and 6 LPS injections.
• Brain tissue was collected after the final injection for immunohistochemical analysis of GFAP, GS, Iba-1, and ferritin expression in specific brain regions like the hypothalamus and hippocampus.

Main Results:

• Single LPS dose increased GFAP expression in the arcuate nucleus (ARC) and hippocampus. Repeated LPS injections further elevated GFAP levels in these areas.
• Glutamine synthetase (GS) expression was significantly higher in the hippocampus of rats receiving repeated LPS.
• Ionized calcium binding adaptor protein-1 (Iba-1) expression was enhanced by single LPS in the paraventricular nucleus (PVN) and hippocampus, with repeated LPS increasing Iba-1 in the retrochiasmatic nucleus (RCA), ARC, PVN, and hippocampus.
• Ferritin-positive cells increased in the hippocampus after both single and repeated LPS treatments.

Conclusions:

• Repeated lipopolysaccharide (LPS) administration robustly stimulates the expression of key glial activation markers in the rat brain.
• The observed increase in glial markers suggests a protective role during prolonged inflammatory challenges.
• These findings highlight the dynamic nature of glial responses to LPS and their potential involvement in neuroprotection.